Leslie Donato - AmerisourceBergen President
| ABCDelisted Stock | USD 191.45 1.55 0.80% |
President
Ms. Leslie E. Donato is Executive Vice President and Chief Strategy Officer of the Company. She brings nearly 30 years of longrange strategy and healthcare industry experience. Most recently at Bayer Pharmaceuticals, Ms. Donato developed an integrated global pharmaceutical strategy and a U.S. growth strategy, oversaw the U.S. business for both hematology and neurology, and led the global strategic marketing team for neurology. Prior to Bayer, Ms. Donato was a Partner at McKinsey Company specializing in healthcare. Throughout her tenure, Ms. Donato has developed extensive expertise in understanding global business development, accelerating strategic growth, driving company transformation and redesign and empowering employee engagement. since 2019.
| Age | 51 |
| Tenure | 5 years |
| Phone | 610 727 7000 |
| Web | https://www.amerisourcebergen.com |
Leslie Donato Latest Insider Activity
Tracking and analyzing the buying and selling activities of Leslie Donato against AmerisourceBergen stock is an integral part of due diligence when investing in AmerisourceBergen. Leslie Donato insider activity provides valuable insight into whether AmerisourceBergen is net buyers or sellers over its current business cycle. Note, AmerisourceBergen insiders must abide by specific rules, including filing SEC forms every time they buy or sell AmerisourceBergen'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Leslie Donato over three months ago Disposition of 1432 shares by Leslie Donato of Cencora subject to Rule 16b-3 |
AmerisourceBergen Management Efficiency
The company has Return on Asset of 0.027 % which means that on every $100 spent on assets, it made $0.027 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 2.3366 %, implying that it generated $2.3366 on every 100 dollars invested. AmerisourceBergen's management efficiency ratios could be used to measure how well AmerisourceBergen manages its routine affairs as well as how well it operates its assets and liabilities.AmerisourceBergen has 5.7 B in debt. AmerisourceBergen has a current ratio of 0.89, suggesting that it has not enough short term capital to pay financial commitments when the payables are due. Note however, debt could still be an excellent tool for AmerisourceBergen to invest in growth at high rates of return.
Similar Executives
| Showing other executives | PRESIDENT Age | ||
| Frederic Pech | EDAP TMS SA | 55 | |
| James CPA | Henry Schein | 70 | |
| John Wright | Patterson Companies | N/A | |
| Jonathan Leon | Owens Minor | 57 | |
| Nancy Flores | McKesson | 54 | |
| Rob Schlissberg | Cardinal Health | N/A | |
| Andrew Long | Owens Minor | 59 | |
| Shana Neal | Owens Minor | 55 | |
| Les Korsh | Patterson Companies | 54 | |
| Mark Zacur | Owens Minor | 57 | |
| Christopher Pendergast | Henry Schein | 61 | |
| Ben Brinker | Cardinal Health | N/A | |
| JeanFrancois Bachelard | EDAP TMS SA | 60 | |
| George Henriques | Patterson Companies | 64 | |
| Paul Guggenheim | Patterson Companies | 64 | |
| Kevin Pohlman | Patterson Companies | 61 | |
| Brian Rice | Cardinal Health | 57 | |
| Patricia English | Cardinal Health | 44 | |
| Nicholas Pace | Owens Minor | 50 | |
| Michele Holcomb | Cardinal Health | 52 | |
| Walter Siegel | Henry Schein | 64 | |
Management Performance
| Return On Equity | 2.34 | |||
| Return On Asset | 0.027 |
AmerisourceBergen Leadership Team
Elected by the shareholders, the AmerisourceBergen's board of directors comprises two types of representatives: AmerisourceBergen inside directors who are chosen from within the company, and outside directors, selected externally and held independent of AmerisourceBergen. The board's role is to monitor AmerisourceBergen's management team and ensure that shareholders' interests are well served. AmerisourceBergen's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, AmerisourceBergen's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Steven Collis, CEO and President Director and Member of Executive Committee | ||
| PharmD Mauch, Ex COO | ||
| James Cleary, Executive Vice President and Presidentident - MWI Veterinary Supply | ||
| Robert Mauch, Executive Vice President, Group President - Pharmaceutical Distribution & Strategic Global Sourcing | ||
| Lonie Haynes, Senior Vice President Chief Diversity and Inclusion Officer | ||
| Bennett Murphy, Vice President Investor Relations | ||
| Ornella Barra, Director | ||
| Richard Gochnauer, Independent Director | ||
| John Chou, Executive Vice President, Chief Legal Officer and Secretary | ||
| Lon Greenberg, Independent Director | ||
| Gina Clark, Executive Vice President, Chief Communications & Administration Officer | ||
| D Durcan, Independent Director | ||
| Dennis Nally, Independent Director | ||
| Kathleen Hyle, Independent Director | ||
| Kathy Gaddes, Chief Human Resource Officer, Executive Vice President | ||
| Elizabeth Campbell, Senior Vice President and Deputy General Counsel | ||
| Silvana Battaglia, Chief Human Resource Officer, Executive Vice President | ||
| Jane Henney, Lead Independent Director | ||
| Leslie Donato, Executive Vice President and Chief Strategy Officer | ||
| Lazarus Krikorian, Senior Vice President Principal Accounting Officer, Corporate Controller | ||
| Henry McGee, Independent Director | ||
| Michael Long, Independent Director |
AmerisourceBergen Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is AmerisourceBergen a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 2.34 | |||
| Return On Asset | 0.027 | |||
| Profit Margin | 0.01 % | |||
| Operating Margin | 0.01 % | |||
| Current Valuation | 41.48 B | |||
| Shares Outstanding | 200.85 M | |||
| Shares Owned By Insiders | 16.68 % | |||
| Shares Owned By Institutions | 78.91 % | |||
| Number Of Shares Shorted | 7.02 M | |||
| Price To Earning | 20.86 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Consideration for investing in AmerisourceBergen Stock
If you are still planning to invest in AmerisourceBergen check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the AmerisourceBergen's history and understand the potential risks before investing.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |